These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8205527)

  • 21. E-cadherin expression as a prognostic factor in transitional cell carcinoma of the bladder after transurethral resection.
    Khorrami MH; Hadi M; Gharaati MR; Izadpanahi MH; Javid A; Zargham M
    Urol J; 2012; 9(3):581-5. PubMed ID: 22903481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.
    Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH
    Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
    Mahnken A; Kausch I; Feller AC; Krüger S
    Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information.
    Popov Z; Gil-Diez de Medina S; Lefrere-Belda MA; Hoznek A; Bastuji-Garin S; Abbou CC; Thiery JP; Radvanyi F; Chopin DK
    Br J Cancer; 2000 Jul; 83(2):209-14. PubMed ID: 10901372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
    De Medina SG; Popov Z; Chopin DK; Southgate J; Tucker GC; Delouvée A; Thiery JP; Radvanyi F
    Oncogene; 1999 Oct; 18(41):5722-6. PubMed ID: 10523852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for bladder cancer.
    Otto T; Goepel M; Heider KH; Rübben H
    Urol Res; 1995; 23(3):137-41. PubMed ID: 7483138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.
    Fukushima H; Koga F; Kawakami S; Fujii Y; Yoshida S; Ratovitski E; Trink B; Kihara K
    Cancer Res; 2009 Dec; 69(24):9263-70. PubMed ID: 19934319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of classic cadherins type I in urothelial neoplastic progression.
    Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
    Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
    Silletti S; Yao JP; Pienta KJ; Raz A
    Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study.
    Cai T; Piazzini M; Nesi G; Taddei I; Sardi I; Detti B; Mondaini N; Dal Canto M; Bartoletti R
    Oncol Rep; 2007 Apr; 17(4):925-30. PubMed ID: 17342338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
    Rao J; Seligson D; Visapaa H; Horvath S; Eeva M; Michel K; Pantuck A; Belldegrun A; Palotie A
    Cancer; 2002 Sep; 95(6):1247-57. PubMed ID: 12216092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
    Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
    Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse relation of autocrine motility factor receptor and E-cadherin expression following MDCK epithelial cell transformation.
    Simard D; Nabi IR
    Biochem Biophys Res Commun; 1996 Feb; 219(1):122-7. PubMed ID: 8619793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
    Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
    Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment of the prognostic evaluation system of T1G3 bladder urothelial cancer].
    Li XD; Sun G; Liu XQ
    Zhonghua Wai Ke Za Zhi; 2013 Aug; 51(8):741-5. PubMed ID: 24252684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autocrine motility factor receptor expression associates with tumor progression in thymoma.
    Ohta Y; Minato H; Tanaka Y; Go T; Oda M; Watanabe Y
    Int J Oncol; 2000 Aug; 17(2):259-64. PubMed ID: 10891533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
    Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
    Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant role of E-cadherin in the progression of bladder cancer.
    Imao T; Koshida K; Endo Y; Uchibayashi T; Sasaki T; Namiki M
    J Urol; 1999 Feb; 161(2):692-8. PubMed ID: 9915485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.